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Background: Childhood obesity has become a serious public health threat worldwide due to its many short- and
long-term adverse health effects. We assessed the association between weight status and metabolic co-morbidities
among South Korean children using nationally representative data.
Methods: Data from the 2007-2008 Korea National Health and Nutrition Examination Surveys for 1,526 children
aged 10-19 years were used. Logistic regression models were fit to examine the association between weight status
[overweight, 85th percentile≤ BMI <95th percentile; obese, BMI ≥95th percentile; and central obesity, waist
circumference ≥90th percentile, based on 2007 Korean National Growth Charts] and metabolic outcomes.
Results: More obese children had metabolic co-morbidities than normal-weight children (P < 0.05). Boys had higher
means BMI than girls, WC, and BP, while girls had higher means of total blood cholesterol and HDL-cholesterol
(P < 0.05). Attributable risk of metabolic syndrome was high due to overweight and obesity: 91.1% for central obesity
and 29.6% for high TG. Obese children had increased risk of having high BP (adjusted odds ratio (OR): 1.90; 95%
CI: 1.05-3.45), dyslipidemia (OR: 6.21; 95% CI: 3.59-10.75), high TG (OR: 6.87; 95% CI: 4.05-11.64), low HDL (OR: 4.46; 95%
CI: 2.23-8.89), and ≥2 co-morbidities (OR: 26.97; 95% CI: 14.95-48.65) compared to normal-weight subjects, while the
associations between weight status and metabolic outcomes were stronger in boys.
Conclusions: Obesity was strongly associated with metabolic co-morbidities in South Korean children.
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WaistBackground
Worldwide prevalence of childhood obesity has increased
remarkably over the past three decades [1]. Overweight or
obese children are at a high risk for developing long-term
chronic conditions, including high blood pressure (BP),
elevated blood glucose, dyslipidemia, and metabolic syn-
drome (MetS) [2,3], which are metabolic co-morbidities of
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reproduction in any medium, provided the orAs South Korea became industrialized, energy intake
and sedentary activities (e.g., screen time) have increased.
Based on the 2011 Korea national health statistics, among
Korean adults aged 30 and older, the prevalence of obesity
(BMI ≥ 30 kg/m2), hypertension, diabetes, hyperchole-
sterolemia, and hypertriglyceridemia is 34.2%, 30.8%,
10.5%, 14.5%, and 16.5%, respectively. The rates have been
increasing [4].
The prevalence of childhood obesity doubled from 5.4%
in 1998 to 10.8% in 2008 in South Korea, although it is
still low compared to Western countries [5,6]. Moreover,
among Korean adolescents body weight status mispercep-
tion (51.6% of boys; 48.6% of girls) is common based on
the 2009 nationally representative data. It is strongly asso-
ciated with poor eating behaviors, and stress or depressed
moods [7]. However, little is known about the association. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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among children in South Korea [6]; previous related stu-
dies were mainly based on data that is 10 years old, and
the gender-age specific association between metabolic co-
morbidities and weight status has not been sufficiently
examined.
To fill this gap, this study assessed the association bet-
ween weight status and metabolic co-morbidities by gen-
der among children aged 10-19 years in South Korea using
nationally representative data. We also investigated the
aspect of metabolic co-morbidities in overweight/obese
children. The findings may help guide future screening of
high-risk groups and guide related interventions.
Methods
Study population and database
We used data from the fourth Korea National Health
and Nutrition Examination Surveys (KNHANES IV,
2007-08). KNHANES is a series of population-based,
cross-sectional surveys that selects a representative
group by using a stratified, multistage sampling design
according to geographic area, age, and gender. Since
2007, the KNHANES has become a year-round investi-
gation with rolling survey sampling. Stratification was
conducted based on the country's 29 areas, including 11
metropolitan cities and provinces, the administrative
unit, and the dwelling type. The instruments included a
health interview survey, a health examination survey, and
a nutrition survey. The health interview survey collected
information regarding socio-demographic characteristics.
Anthropometry, BP measures and laboratory tests of the
subjects were obtained by direct health examination in a
mobile examination center. Detailed descriptions of the
study design and data collection have been published
[8]. The KNHANES IV was approved by the Korea
Centers for Disease Control & Prevention Institutional
Review Board.
Blood sample laboratory tests among children under
10 years of age were not available. We focused on a
sample of 3,618 children (1,658 boys and 1,510 girls) aged
10-19 years with complete demographic data. After ex-
cluding 645 subjects without body mass index (BMI) mea-
sures and 1,447 subjects without metabolic co-morbidities
parameters such as waist circumference (WC), BP, glu-
cose, triglyceride (TG) and total cholesterol (TC), and
high-density lipoprotein cholesterol (HDL-C), we had a
final sample of 1,526 subjects (821 boys and 705 girls) for
our analyses.
Data collection and key measurements
Anthropometric measures
Standing height (seca 225, SECA, Germany) and weight
(GL-6000-20, CASKOREA Co., Ltd., Korea) were obtained
using standardized techniques and equipment. WC wasmeasured at the midpoint between the subcostal bottom
and the top of the iliac crest using a fiberglass tape (seca
200, SECA, Germany).
Blood pressure (BP)
Three BP determinations were obtained by standard
methods with the subject in a sitting position using a
mercury sphygmomanometer. After rest while seated,
BP was measured 3 times at 30 second intervals. The
average of the second and third measurements was used
in our analysis.
Laboratory tests
All blood specimen collection and processing instructions
are described in the KNHANES Laboratory/Medical Tech-
nologists Procedures Manual [9]. Blood samples were col-
lected in the morning after fasting for at least 8 hours.
Fasting blood glucose was analyzed using a reaction bet-
ween glucose and ATP catalyzed by the enzyme hexoki-
nase. The concentrations of TG, TC, and HDL-C were also
measured using an enzymatic method. Fasting blood glu-
cose, TG, TC, and HDL-C levels were measured using an
automated hematology analyzer (ADVIA 1650, Siemens,
USA) in a central, certified laboratory. The low-density
lipoprotein cholesterol (LDL-C) concentration was esti-
mated by the Friedewald formula (LDL cholesterol = total
cholesterol-HDL cholesterol-triglycerides/5) [10].
Definition of weight status
To define weight status, BMI was calculated based on
measured weight and height (BMI = weight (kg)/squared
height (m2)). We used the 2007 Korean National Growth
Charts [11]. Subjects were classified as a) normal weight,
5th percentile ≤ BMI < 85th percentile; b) overweight, 85th
percentile ≤ BMI < 95th percentile; c) obese, BMI ≥ 95th
percentile [11].
Central obesity is defined as WC ≥ 90th percentile for
age and gender based on 2007 Korea Growth Charts
[11] in children aged 10 to < 16 yrs., and ≥ 90 cm for
men and ≥ 85 cm for women as the Korean-specific cri-
terion [12] in adolescents aged ≥ 16 yrs.
Definition of metabolic co-morbidities
The definition of metabolic co-morbidities for our study
was as follows:
1) Prehypertension and hypertension [13]: systolic
BP/diastolic BP ≥ 90th percentile for age, gender,
and height based on 2007 Korea Growth Chart [11]
2) High glucose [14]: fasting blood glucose ≥
100 mg/dL [14]
3) Dyslipidemia [15]: high TG, high TC, high LDL-C,
or low HDL-C [15]
i) High TG: Triglyceride > 150 mg/dL
Lim et al. BMC Public Health 2014, 14:279 Page 3 of 9
http://www.biomedcentral.com/1471-2458/14/279ii) High TC: Total cholesterol > 200 mg/dL
iii)LDL-cholesterol > 130 mg/dL
iv)HDL-cholesterol < 35 mg/dL
4) Metabolic syndrome: Having central obesity plus ≥ 2
of the following criteria based on the 2007 pediatric
International Diabetes Federation (IDF)
definition [16]
i) elevated BP: systolic BP ≥ 130 or diastolic BP ≥
85 mm Hg, or treatment of previously diagnosed
hypertension
ii) elevated fasting plasma glucose: ≥ 100 mg/dL
(5.6 mmol/L), or previously diagnosed type 2
diabetes
iii) elevated TG level: ≥ 150 mg/dL (1.7 mmol/L), or
specific treatment for this lipid abnormality
iv) reduced HDL cholesterol: < 40 mg/dL
(1.03 mmol/L) in children aged 10-16 yrs and
boys aged 16-19 yrs, and < 50 mg/dL
(1.29 mmol/L) in girls aged 16-19 yrs, or specific
treatment for this lipid abnormality
Statistical analysis
Our key outcome variables were the presence of metabolic
co-morbidities (e.g., central obesity, high BP, high glucose,
dyslipidemia, metabolic syndrome). The key exposure cat-
egorical variable was weight status classified as normal
weight, overweight, obesity, and central obesity. Analysis
stratified by age and gender was conducted. The complex
sample design was taken into account in the analysis using
STATA release 11.0 survey-related commands, to give
nationally representative estimates and correct estimates
of the related variances.
First, we examined the gender and weight status diffe-
rences in metabolic co-morbidities. Between-group diffe-
rences in means were tested using t test and ANOVA, and
the prevalence differences of metabolic co-morbidities
were tested using χ2 tests. We also tested the trends across
weight status (normal weight, overweight, obesity) and
calculated population attributable risk (PAR, %) [17].
Then, to examine the association between weight sta-
tus and metabolic co-morbidities (outcome variables),
we fitted logistic regression models, controlling for so-
cioeconomic and other environmental factors, including
urban-rural residence region, household income as the
quartiles of average household monthly income, and me-
narche status (for girls).
Results
Prevalence of metabolic co-morbidities by gender and
weight status
Most participants (81.6%) lived in urban areas. Age dis-
tribution, urban-rural residence region, and household
income did not differ significantly across the three cat-
egories of weight status. Table 1 shows the distributionof metabolic outcomes by gender and weight status. Boys
suffered worse metabolic outcomes in terms of high WC
level and elevated BP level compared to girls, whereas girls
had higher mean TC and HDL-C levels (P < 0.05) than
boys. Obese children had significantly higher means for
most metabolic outcomes (e.g., BMI, WC, BP, TG, TC,
LDL-C, atherogenic index = defined as log (TG/HDL-C),
waist-to-height ratio); while, mean HDL-C level was the
highest among normal-weight children (all P < 0.05).
Regarding prevalence of metabolic abnormalities, obese
children had a high prevalence of MetS, central obesity,
high BP, dyslipidemia and all individual blood lipid pro-
files (P < 0.05), except for the prevalence of high glucose
(P > 0.05). In addition, the proportion of children with 2
or more metabolic co-morbidities is higher among over-
weight and obese children than their normal weight coun-
terparts (5.7% in normal weight vs. 17.5% in overweight
vs. 60.3% in obese children, P < 0.05).
Attributable risk of metabolic comorbidities to
overweight or obesity by gender
Overall, the risk of metabolic co-morbidities attributable
to overweight or obesity was high for MetS (100.0%),
central obesity (91.1%), and ≥ 2 metabolic co-morbidities
(47.3%); modest for high TG (29.6%), dyslipidemia
(20.2%), and low HDL (17.7%); and relatively low for
high BP (7.7%) and high glucose (10.0%) (Figure 1). Boys
had high attributable risk rates of metabolic co-
morbidities compared to girls, except for the attributable
risk due to high glucose (6.1% in boys vs. 14.4% in girls).
Association between weight status and metabolic co-
morbidities by gender
Table 2 shows the associations between weight status and
metabolic co-morbidities. After adjusting for age, gender,
income, urban-rural residence, and menarche status (only
for girls), the estimates showed that: 1) obese children
were more likely to have high BP (OR, 1.90; 95% CI, 1.05-
3.45), dyslipidemia (OR, 6.21; 95% CI, 3.59-10.75), high
TG (OR, 6.87; 95% CI, 4.05-11.64), high TC (OR, 2.80;
95% CI, 1.10-5.62), high LDL (OR, 3.81; 95% CI, 1.87-
7.80), low HDL (OR, 4.46; 95% CI, 2.23-8.89), and ≥ 2
co-morbidities (OR: 26.97; 95% CI: 14.95-48.65) than
normal-weight subjects (P < 0.05); and 2) centrally obese
children had higher risks of having dyslipidemia (OR,
3.87; 95% CI, 2.45-6.13), other blood lipid profiles (OR,
2.04-4.12, P < 0.05), and ≥ 2 co-morbidities (OR: 19.90;
95% CI: 12.09-32.76) than children who were not centrally
obese.
Our results suggested strong associations between
weight status and metabolic outcomes in boys, in par-
ticular. In contrast, co-morbidities such as high BP, high
TC, high LDL, and low HDL were not significantly asso-
ciated with weight status in girls. However, centrally
Table 1 Means and proportions of metabolic outcomes by gender and weight status among children aged 10-19-y-old
in South Korea: KNHANES 2007-20081
By gender By weight status2,3,4
Total Boys Girls Normal weight Overweight Obese
(n = 1526) (n = 821) (n = 705) (n = 1147) (n = 194) (n = 90)
Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE
Anthropometry
Body mass index (kg/m2) 20.5 0.1 21.0 0.2 20.0 0.15 19.6 0.1c 24.7 0.1b 28.9 0.4a
Waist circumference (cm) 70.0 0.3 72.2 0.5 67.3 0.45 67.4 0.3c 80.3 0.6b 90.3 1.5a
Systolic blood pressure (mmHg) 104.0 0.4 106.5 0.5 101.0 0.45 102.9 0.4c 108.0 0.9b 112.9 1.5a
Diastolic blood pressure (mmHg) 65.4 0.4 66.7 0.5 64.0 0.55 65.0 0.4b 67.6 0.9a 67.6 1.5a
Laboratory tests
Triglycerides (mg/dL) 90.8 1.9 89.6 2.7 92.1 2.4 82.9 1.7c 119.3 8.4b 142.0 10.6a
Total cholesterol (mg/dL) 157.8 0.9 155.5 1.2 160.5 1.15 155.6 1.0c 167.0 2.2b 175.9 3.0a
LDL-cholesterol (mg/dL) 89.9 0.8 88.8 1.1 91.2 1.1 88.5 0.9c 96.2 2.1b 105.2 3.2a
HDL-cholesterol (mg/dL) 49.7 0.5 48.8 0.6 50.8 0.65 50.6 0.6a 47.0 0.9b 42.2 1.4c
Fasting blood glucose (mg/dL) 89.3 0.4 89.6 0.5 88.8 0.4 89.0 0.3b 91.6 1.3a 89.8 1.0ab
Atherogenic index7 -0.3 0.0 -0.3 0.0 -0.3 0.0 -0.4 0.0c -0.1 0.1b 0.3 0.2a
Waist-to-height ratio 0.4 0.0 0.4 0.0 0.4 0.05 0.4 0.0c 0.5 0.0b 0.6 0.0a
% % % % % %
Obesity status
Central obesity, %8 8.1 8.9 7.2 0.9 20.8 77.66
Overweight and obesity, %2 19.0 21.0 16.7
Cadiometabolic risk factors
Metabolic syndrome, %6 1.9 2.4 1.3 0.0 3.2 24.76
High blood pressure, %7 17.5 20.0 14.76 15.9 22.6 28.46
High glucose, %8 6.7 7.1 6.3 6.5 8.0 9.2
Dyslipidemia, %9 21.2 21.8 20.4 16.2 38.2 55.46
High triglycerides, %9 10.2 10.0 10.4 6.9 21.5 33.16
High total cholesterol, %9 6.2 5.6 6.8 5.0 10.8 14.46
High LDL-cholesterol, %9 5.6 5.2 6.0 4.4 7.8 16.36
Low HDL-cholesterol, %9 7.9 9.2 6.3 6.1 12.0 23.26
No. of metabolic comorbidities, %10
0 61.4 60.8 62.2 69.2 36.1 8.96
1 28.4 28.8 27.9 25.2 46.4 30.8
≥ 2 10.2 10.4 10.0 5.7 17.5 60.3
Abbreviations: KNHANES Korea National Health and Nutrition Examination Survey, LDL-cholesterol Low density lipoprotein cholesterol, HDL-cholesterol high density
lipoprotein cholesterol.
1Estimates shown as mean and standard error or %.
2Defined using 2007 Korea growth chart, Normal weight (5th percentile ≤ BMI < 85th percentile); overweight (85th percentile ≤ BMI < 95th percentile); obesity
(BMI ≥ 95th percentile).
3P-trend <0.05 across weight status.
4Letters with different superscripts by weight status are significantly different at P<0.05 by Tukey’s multiple range test.
5P < 0.05 for between group comparisons.
6P < 0.05 for between group comparisons using χ2 tests.
7Atherogenic index = log (triglyceride/HDL-cholesterol).
8Definitions of metabolic co-morbidities are provided in Methods.
9Among elevated waist circumference, elevated triglycerides, reduced HDL cholesterol, elevated blood pressure, elevated fasting plasma glucose based on the
2007 pediatric IDF definition.
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Figure 1 Risk of metabolic comorbidities attributable to overweight and obesity among children aged 10-19-y-old in South Korea:
KNHANES 2007-2008. KNHANES, Korea National Health and Nutrition Examination Survey; HDL-C, high density lipoprotein cholesterol. 1Unadjusted
population attributable risks estimated based on the method developed by Fleiss [15]. 2Definitions of metabolic co-morbidities are provided in
Methods. 3Among elevated waist circumference, elevated triglycerides, reduced HDL cholesterol, elevated blood pressure, elevated fasting plasma
glucose based on the 2007 pediatric IDF definition.
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(OR: 3.24; 95% CI: 1.37-7.64) than girls with normal
WC.
Discussion
We examined the association between weight status and
metabolic co-morbidity among children by gender using
the 2007-08 nationally representative data in South Korea.
Obese, including centrally obese, children had a higher
prevalence of metabolic co-morbidities than normal-
weight children. Overweight or obese children had also
higher attributable risks of MetS, central obesity, and
higher TG. Our results showed strong associationsbetween weight status and metabolic outcomes for boys,
in particular. Hyperglycemia was a significantly higher risk
outcome among centrally obese girls only. Our findings
suggest that dyslipidemia, in particular high TG, was a key
co-morbidity, which is affected by increased body weight.
Overall prevalence of MetS in our participants (1.9%)
was similar to a previous study based on the 2005
KNHANES (1.8%) [18]. Korean adolescents had a slightly
higher MetS prevalence based on the IDF criteria than
adolescents from some other Asian countries (e.g., 1.2% in
Hong Kong Chinese [19], 1.5% in Asian Indian adoles-
cents [20]), but a lower rate than US adolescents (5.5%)
[21] and Finland adolescents (2.4%) [22].
Table 2 Associations (OR and 95% CI) between overweight and obesity and individual metabolic comorbidities among children aged 10-19-y-old in South
Korea: KNHANES 2007-20081,2
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8
High blood pressure3 High glucose4 Dyslipidemia5 High triglyceride4 High cholesterol5 High LDL-C5 Low HDL-C5 ≥2 of MetS components6
In boys and girls
Overweight7 1.46 (0.94-2.28) 1.27 (0.64-2.51) 3.36 (2.35-4.81) 3.80 (2.29-6.30) 2.33 (1.27-4.30) 1.91 (0.98-3.74) 2.17 (1.14-4.11) 3.83 (2.25-6.52)
Obese7 1.90 (1.05-3.45) 1.54 (0.68-3.47) 6.21 (3.59-10.75) 6.87 (4.05-11.64) 2.80 (1.10-5.62) 3.81 (1.87-7.80) 4.46 (2.23-8.89) 26.97 (14.95-48.65)
Central obesity8 1.15 (0.69-1.90) 1.65 (0.82-3.35) 3.87 (2.45-6.13) 4.12 (2.67-6.37) 2.04 (1.07-3.90) 3.01 (1.58-5.74) 3.78 (1.81-7.90) 19.90 (12.09-32.76)
In boys
Overweight7 1.31 (0.78-2.21) 1.21 (0.49-2.99) 5.00 (3.07-8.13) 6.28 (3.11-12.7) 2.91 (1.30-6.49) 2.65 (1.16-6.03) 2.64 (1.25-5.57) 5.31 (2.52-11.18)
Obese7 2.32 (1.08-4.98) 1.18 (0.31-4.45) 10.10 (4.84-21.07) 11.50 (5.24-25.02) 5.17 (1.78-14.95) 6.50 (2.66-15.91) 5.49 (2.42-12.42) 36.30 (16.93-77.84)
Central obesity8 1.42 (0.75-2.68) 1.04 (0.32-3.34) 5.32 (3.02-9.37) 5.35 (2.83-10.10) 3.65 (1.59-8.35) 5.80 (2.66-12.67) 3.65 (1.65-8.07) 23.59 (12.16-45.76)
In girls
Overweight7 1.55 (0.70-3.43) 0.83 (0.28-2.51) 1.93 (1.05-3.53) 1.95 (0.86-4.41) 2.05 (0.72-5.90) 1.68 (0.48-5.92) 1.66 (0.55-5.05) 2.69 (1.18-6.14)
Obese7 0.99 (0.31-3.17) 1.71 (0.57-5.09) 2.37 (1.20-4.71) 3.04 (1.38-6.71) 0.75 (0.15-3.85) 1.30 (0.34-4.97) 1.64 (0.50-5.36) 13.84 (6.45-29.70)
Central obesity8 0.64 (0.24-1.69) 3.24 (1.37-7.64) 2.13 (1.14-3.95) 2.87 (1.39-5.91) 0.77 (0.21-2.88) 1.10 (0.36-3.38) 2.66 (0.94-7.55) 16.79 (8.51-33.11)
Abbreviations: KNHANES Korean National Health and Nutrition Examination Survey, OR odds ratio, CI confidence interval.
1Each logistic regression model adjusted for age, gender, income, and urban-rural residence; among girls, further controlled for menarche status.
2Normal weight (5th percentile ≤ BMI < 85th percentile) group was the reference group in each model.
3Systolic blood pressure/diastolic blood pressure ≥ 90th percentiles of 2007 Korean CDC growth chart.
4Fasting blood glucose ≥ 100 mg/dL.
5Triglyceride > 150 mg/dL or Total cholesterol > 200 mg/dL or LDL-cholesterol: > 130 mg/dL or HDL-cholesterol: < 35 mg/dL.
6Among elevated waist circumference, elevated triglycerides, reduced HDL cholesterol, elevated blood pressure, elevated fasting plasma glucose based on the 2007 pediatric IDF definition.
7By BMI percentile of 2007 Korea growth chart, overweight (85th percentile ≤ BMI < 95th percentile); obesity (BMI ≥ 95th percentile).
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valence was higher than the previous 2005 KNHANES re-
sults (among overweight: 3.2% in 2007-08 vs. 1.5%, among
obese: 24.7% vs. 14.7%) [18]. This is likely due to their
higher adiposity among the overweight and obese children
over time. The MetS rate in obese South Korean children
was higher than in those from other populations of chil-
dren and adolescents, e.g., 19.4% among Norwegians [23]
and 10.3% among obese Chinese [24]. However, it should
be noted that these studies focused on slightly different
age ranges and used different MetS diagnosis criteria.
Obese children had a higher prevalence of most me-
tabolic co-morbidities than non-obese children. These
findings were consistent with the data reported for se-
veral other populations such as Mexican [25], Iranian
[26], US [27], German [28], and Chinese [29] children.
For example, risk of MetS was 16 times higher in US
overweight adolescents compared to those with normal
weight (BMI < 85th percentile) (14.5% vs. 0.9%) [27]. In a
study from China, a slightly increasing trend of metabolic
parameter levels was found at the 75th percentile of BMI
and a significant increase was found when BMI ≥ 85th per-
centile [29].
Interestingly, in our subjects, the overall prevalence of
elevated BP (prehypertension and hypertension) was
17.5% and 21.2% of dyslipidemia, higher than other
Asian populations [30-33]. According to a school-based
population study of 88,974 Chinese adolescents, the
prevalence was 10.3% [30]. Prehypertension can be pre-
dictive of future hypertension [34]. Our findings are con-
sistent with the observation that pediatric hypertension
is increasing with the rising pediatric obesity epidemic
[35]. In South Korea, unlike for adults, blood pressure
measurement is not a component of regular health ex-
aminations for children, thus, future monitoring and
prevention efforts are needed to address this high pre-
valence. In terms of dyslipidemia, the prevalences were
11.1% in Chinese [32] and about 11.9% in Thai children
[33], although differences exist on the definition of dys-
lipidemia. Most studies regarding dyslipidemia indicated
that overweight and obese children were more likely to
have dyslipidemia [36,37]. However, there are no local,
official criteria of dyslipidemia for Korean children.
Boys had higher metabolic outcomes such as BMI,
WC, BP levels and waist-to-height ratios; whereas, girls
had higher TC and HDL levels. These gender differences
were consistent with previous findings in other studies
among adolescents in China [32] and even young adults
aged 15-39 years among Asian Indians [38]. Likewise,
boys may be the more vulnerable than girls to the risks
of childhood metabolic disorders. Studying the reasons
for boys' higher risks could shed some light on why the
metabolic disorders are generally on the rise. Based on
the same KNHANES 2007-08 data, South Korean menaged 20-65 years suffered worse metabolic outcomes
than women (all P < 0.05), e.g., MetS: 15.8% in men vs.
11.6% in women, and had a higher average number of
metabolic disturbances [39].
In addition, our results suggest a stronger association
between childhood obesity and high TG (OR = 5.3 in
1998 KNHANES [6] in vs. 6.9 in 2007-08 KNHANES,
compared to children of normal weight). With few ex-
ceptions, the associations between overweight (including
obese and centrally obese) and individual metabolic co-
morbidities were stronger in boys than in girls. Boys are
therefore a more vulnerable group regarding metabolic
outcomes, which may then lead to high risk of heart
disease and other chronic diseases in adulthood. Ad-
ditionally, Korean boys underestimated their weight [40];
therefore, we should help them to achieve a healthy
body weight.
Previous research has suggested that obese children
tend to have a higher risk of hyperglycemia and im-
paired fasting glucose [41]. However, our estimates do
not show a difference in fasting blood glucose level and
proportion of high glucose by weight status. Although a
previous Korean study suggested that hyperglycemia is
the most common individual component of the MetS in
Korean adolescents (approximately 30% in both 1998
and 2001) [18], we did not find the same trend. Further
studies need to verify this discrepancy. Nevertheless, we
found that centrally obese girls tend to have 3 times
higher risk of having elevated blood glucose compared
to non-centrally obese girls. Similar findings were re-
ported in studies about adult women in Sweden [42] and
China [43].
In the present study, overweight or obese children had
high attributable risks of MetS and central obesity. High
TG (around 30% attributable risk) follows, which confers
the highest risk of individual co-morbidities. While there
is no or a very low prevalence of metabolic co-morbidities
among normal-weight children, obese children had a high
prevalence of MetS and central obesity. At present, over-
all, Korean children have little understanding of MetS,
central obesity, or dyslipidemia. The importance of related
health education was undervalued. Therefore, education
programs to improve children’s recognition of these health
dangers and their possible outcomes are needed.
This study has several key strengths. First, it was based
on a recent, nationally representative sample in South
Korea, and our analysis took into account the complex
sampling design effect to provide representative esti-
mates. Moreover, we investigated several metabolic co-
morbidities of overweight or obesity among children.
On the other hand, our study could not employ longi-
tudinal models due to data limitations which preclude
causal inference and the estimates may suffer from prob-
lems such as reverse causation. Then, we categorized
Lim et al. BMC Public Health 2014, 14:279 Page 8 of 9
http://www.biomedcentral.com/1471-2458/14/279several variables of anthropometric and biochemical
measurements. Categorization is a common practice in
biomedical research, which facilitates the interpretation
of model parameters and provides meaningful estimates
with important clinic and public health implications.
This is in line with the aims and scope of this study.
However, the limitations of categorization should also be
noted because the information in the data is not fully
utilized. Future research that examines relevant variables
on a continuous scale is warranted and could potentially
help provide more insight. In addition, subjects were ex-
cluded in the analysis if weight or metabolic comorbidi-
ties were not measured, which limited our sample size
and could potentially introduce selection bias. However,
we explored the possibility of potential selection bias
and our analysis did not suggest significant difference
between the study sample and the whole sample. More-
over, the KHANES is the only available data set that can
be used to examine the levels of biochemical indicators
and estimate the prevalence patterns of chronic condi-
tions at a national level. However, despite of the limita-
tions, such as missing values, existing studies indicate
that KNHANES can still provide valid and reasonably
representative estimates, e.g. the prevalence of metabolic
disorders among children [6,18,21].Conclusions
Childhood obesity is becoming a serious public health
problem in South Korea, as 19.0% of children were over-
weight or obese, and 8.1% had central obesity. The pre-
valence of elevated BP (17.5%) and dyslipidemia (21.2%)
was high among children in South Korea. In addition,
most of the obese children (91.1%) had at least one meta-
bolic co-morbidity. MetS and dyslipidemia, especially high
TG, were the key co-morbidities among obese children.
Lipid profiles of South Korean children are affected by
their weight status. Intervention programs are needed to
prevent and control obesity and its co-morbidities, in par-
ticular targeting at obesity in children.
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